| KEGG_CHEMOKINE_SIGNALING_PATHWAY |
160 |
2.22 |
0 |
0 |
0 |
0.275 |
0.098 |
0.25 |
0 |
0 |
0 |
| KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY |
48 |
2.021 |
0 |
0 |
0 |
0.292 |
0.123 |
0.256 |
0 |
0 |
0 |
| KEGG_CELL_ADHESION_MOLECULES_CAMS |
100 |
1.994 |
0 |
0 |
0 |
0.21 |
0.04 |
0.202 |
0 |
0 |
0 |
| KEGG_HEMATOPOIETIC_CELL_LINEAGE |
62 |
1.981 |
0 |
0 |
0 |
0.258 |
0.043 |
0.248 |
0 |
0 |
0 |
| KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION |
209 |
1.922 |
0 |
0.003 |
0.02 |
0.268 |
0.117 |
0.239 |
0 |
0 |
0 |
| KEGG_ASTHMA |
14 |
1.862 |
0 |
0.007 |
0.06 |
0.357 |
0.082 |
0.328 |
0 |
0 |
0 |
| KEGG_PRIMARY_IMMUNODEFICIENCY |
33 |
1.773 |
0 |
0.017 |
0.16 |
0.303 |
0.082 |
0.279 |
0 |
0 |
0 |
| KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS |
36 |
1.711 |
0 |
0.026 |
0.26 |
0.389 |
0.082 |
0.357 |
0 |
0 |
0 |
| KEGG_GRAFT_VERSUS_HOST_DISEASE |
14 |
1.698 |
0 |
0.028 |
0.28 |
0.571 |
0.156 |
0.483 |
0 |
0 |
0 |
| KEGG_ALLOGRAFT_REJECTION |
16 |
1.696 |
0 |
0.025 |
0.28 |
0.5 |
0.172 |
0.414 |
0 |
0 |
0 |
| KEGG_COMPLEMENT_AND_COAGULATION_CASCADES |
55 |
1.681 |
0 |
0.027 |
0.3 |
0.255 |
0.08 |
0.235 |
0 |
0 |
0 |
| KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY |
93 |
1.669 |
0 |
0.029 |
0.34 |
0.301 |
0.117 |
0.267 |
0 |
0 |
0 |
| KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY |
97 |
1.618 |
0 |
0.042 |
0.46 |
0.289 |
0.139 |
0.25 |
0 |
0 |
0 |
| KEGG_OTHER_GLYCAN_DEGRADATION |
16 |
1.6 |
0.091 |
0.045 |
0.52 |
0.312 |
0.13 |
0.272 |
0.048 |
0 |
0 |
| KEGG_RETINOL_METABOLISM |
28 |
1.591 |
0 |
0.046 |
0.56 |
0.25 |
0.07 |
0.233 |
0.046 |
0 |
0 |
| KEGG_LEISHMANIA_INFECTION |
50 |
1.508 |
0 |
0.085 |
0.8 |
0.38 |
0.108 |
0.34 |
0.07 |
0 |
0 |
| KEGG_RENIN_ANGIOTENSIN_SYSTEM |
15 |
1.472 |
0.136 |
0.096 |
0.84 |
0.533 |
0.216 |
0.419 |
0.084 |
0 |
0 |
| KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY |
48 |
1.461 |
0 |
0.095 |
0.86 |
0.229 |
0.091 |
0.209 |
0.082 |
0 |
0 |
| KEGG_DRUG_METABOLISM_OTHER_ENZYMES |
28 |
1.427 |
0 |
0.112 |
0.92 |
0.25 |
0.07 |
0.233 |
0.101 |
0 |
0 |
| KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY |
72 |
1.403 |
0 |
0.123 |
0.94 |
0.403 |
0.166 |
0.337 |
0.117 |
0 |
0 |
| KEGG_TYPE_I_DIABETES_MELLITUS |
21 |
1.385 |
0.048 |
0.135 |
0.96 |
0.524 |
0.219 |
0.409 |
0.136 |
0 |
0 |
| KEGG_DRUG_METABOLISM_CYTOCHROME_P450 |
40 |
1.383 |
0 |
0.129 |
0.96 |
0.25 |
0.075 |
0.232 |
0.13 |
0 |
0 |
| KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES |
13 |
1.375 |
0.111 |
0.129 |
0.96 |
0.154 |
0.034 |
0.149 |
0.128 |
0 |
0 |
| KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION |
227 |
1.354 |
0 |
0.147 |
0.96 |
0.322 |
0.245 |
0.245 |
0.142 |
0 |
0 |
| KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION |
105 |
1.326 |
0 |
0.169 |
0.96 |
0.219 |
0.106 |
0.197 |
0.168 |
0 |
0 |
| KEGG_TYROSINE_METABOLISM |
32 |
1.323 |
0.13 |
0.165 |
0.96 |
0.125 |
0.044 |
0.12 |
0.163 |
0 |
0 |
| KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 |
37 |
1.32 |
0.087 |
0.162 |
0.96 |
0.243 |
0.075 |
0.225 |
0.158 |
0 |
0 |
| KEGG_JAK_STAT_SIGNALING_PATHWAY |
131 |
1.32 |
0 |
0.156 |
0.96 |
0.305 |
0.223 |
0.239 |
0.152 |
0 |
0 |
| KEGG_APOPTOSIS |
76 |
1.302 |
0.045 |
0.169 |
0.98 |
0.25 |
0.169 |
0.208 |
0.159 |
0 |
0 |
| KEGG_LYSOSOME |
112 |
1.299 |
0 |
0.164 |
0.98 |
0.295 |
0.185 |
0.241 |
0.157 |
0 |
0 |
| KEGG_GLYCOSAMINOGLYCAN_DEGRADATION |
19 |
1.292 |
0.095 |
0.166 |
1 |
0.211 |
0.096 |
0.191 |
0.163 |
0 |
0 |
| KEGG_AUTOIMMUNE_THYROID_DISEASE |
26 |
1.289 |
0.143 |
0.163 |
1 |
0.423 |
0.25 |
0.318 |
0.158 |
0 |
0 |
| KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY |
77 |
1.202 |
0.077 |
0.274 |
1 |
0.234 |
0.113 |
0.208 |
0.279 |
0 |
0 |
| KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION |
30 |
1.2 |
0.13 |
0.267 |
1 |
0.4 |
0.221 |
0.312 |
0.271 |
0 |
0 |
| KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY |
60 |
1.161 |
0.208 |
0.321 |
1 |
0.25 |
0.169 |
0.208 |
0.334 |
0 |
0 |
| KEGG_OLFACTORY_TRANSDUCTION |
27 |
1.12 |
0.222 |
0.374 |
1 |
0.148 |
0.08 |
0.136 |
0.381 |
0 |
0 |
| KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY |
102 |
1.119 |
0.191 |
0.367 |
1 |
0.245 |
0.143 |
0.211 |
0.376 |
0 |
0 |
| KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS |
86 |
1.089 |
0.25 |
0.41 |
1 |
0.163 |
0.058 |
0.154 |
0.414 |
0 |
0 |
| KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM |
10 |
1.082 |
0.409 |
0.41 |
1 |
0.4 |
0.163 |
0.335 |
0.407 |
0 |
0 |
| KEGG_PPAR_SIGNALING_PATHWAY |
61 |
1.08 |
0.25 |
0.403 |
1 |
0.361 |
0.239 |
0.275 |
0.397 |
0 |
0 |
| KEGG_ABC_TRANSPORTERS |
36 |
1.076 |
0.391 |
0.401 |
1 |
0.333 |
0.178 |
0.275 |
0.398 |
0 |
0 |
| KEGG_VIRAL_MYOCARDITIS |
48 |
1.034 |
0.333 |
0.468 |
1 |
0.125 |
0.046 |
0.119 |
0.458 |
0 |
0 |
| KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY |
63 |
1.025 |
0.429 |
0.479 |
1 |
0.254 |
0.195 |
0.205 |
0.478 |
0 |
0 |
| KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES |
20 |
1.001 |
0.611 |
0.52 |
1 |
0.1 |
0.032 |
0.097 |
0.503 |
0 |
0 |
| KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS |
46 |
0.969 |
0.632 |
0.569 |
1 |
0.109 |
0.052 |
0.103 |
0.559 |
0 |
0 |
| KEGG_GLYCOLYSIS_GLUCONEOGENESIS |
53 |
0.962 |
0.524 |
0.568 |
1 |
0.113 |
0.071 |
0.105 |
0.564 |
0 |
0 |
| KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS |
13 |
0.885 |
0.611 |
0.719 |
1 |
0.231 |
0.07 |
0.215 |
0.715 |
0 |
0 |
| KEGG_ASCORBATE_AND_ALDARATE_METABOLISM |
12 |
0.879 |
0.68 |
0.716 |
1 |
0.333 |
0.071 |
0.31 |
0.717 |
0 |
0 |
| KEGG_TYPE_II_DIABETES_MELLITUS |
42 |
0.857 |
0.706 |
0.746 |
1 |
0.286 |
0.165 |
0.239 |
0.733 |
0 |
0 |
| KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS |
14 |
0.57 |
1 |
0.987 |
1 |
0.429 |
0.301 |
0.3 |
0.986 |
0.44 |
0 |